Sanaria Inc.
Clinical trials sponsored by Sanaria Inc., explained in plain language.
-
Scientists test genetically weakened parasite as a malaria vaccine
⭐️ VACCINE ⭐️ Not yet recruitingThis is the first human study of a new malaria vaccine called PfSPZ-LARC2. It uses a live but genetically weakened malaria parasite that is designed to stop developing in the liver, preventing a full-blown infection. The main goals are to see if the vaccine is safe and tolerable …
Phase: PHASE1 • Sponsor: Sanaria Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:29 UTC
-
New vaccine aims to stop malaria before it makes you sick
⭐️ VACCINE ⭐️ Not yet recruitingThis study is testing a new malaria vaccine designed to stop the malaria parasite in the liver before it can enter the bloodstream and cause illness. It will involve 180 healthy adults in Burkina Faso to see if one or two doses are safe and can protect them from getting malaria d…
Phase: PHASE2 • Sponsor: Sanaria Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 24, 2026 12:01 UTC